clarithromycin has been researched along with Hypokalemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Karmakar, S; Padman, A; Sen, T; Swamy Mane, N | 1 |
Hashimoto, T; Hayashi, Y; Ikeda, U; Mitsuhashi, T; Shimada, K; Watanabe, T | 1 |
2 other study(ies) available for clarithromycin and Hypokalemia
Article | Year |
---|---|
Hypokalemia: a potent risk for QTc prolongation in clarithromycin treated rats.
Topics: Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Dietary Supplements; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Electrocardiography; Electrolytes; Furosemide; Heart; Hypokalemia; Male; Potassium, Dietary; Rats; Rats, Wistar; Risk Factors; Severity of Illness Index; Suspensions | 2013 |
Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia.
Topics: Aged; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Disopyramide; Electrocardiography; Female; Humans; Hypokalemia; Mixed Function Oxygenases; Myocardial Infarction; Respiratory Tract Infections; Torsades de Pointes | 1999 |